Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 51.87 | N/A |
| PEG Ratio (TTM) | -5.33 | N/A |
| P/S Ratio (TTM) | 1.05 | N/A |
| P/B Ratio (TTM) | 3.47 | N/A |
| P/FCF Ratio (TTM) | 29.91 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.98% | N/A |
| ROE (TTM) | 10.92% | N/A |
| Net Profit Margin (TTM) | 2.00% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -9.99% | N/A | N/A |
| Revenue | 11.77% | N/A | N/A |
| Net Income | -11.39% | N/A | N/A |
| Cash Flow | 70.51% | N/A | N/A |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.71 | N/A |
| Quick Ratio (TTM) | 1.71 | N/A |
| D/E Ratio (TTM) | 0.86 | N/A |
| Interest Coverage (TTM) | 3.29 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 1.54 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |